Northern Trust’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.02M Sell
375,977
-90,606
-19% -$486K ﹤0.01% 2983
2025
Q1
$2.49M Buy
466,583
+8,349
+2% +$44.6K ﹤0.01% 2800
2024
Q4
$4.1M Buy
458,234
+19,893
+5% +$178K ﹤0.01% 2622
2024
Q3
$4.83M Buy
438,341
+22,081
+5% +$243K ﹤0.01% 2495
2024
Q2
$3.79M Sell
416,260
-13,633
-3% -$124K ﹤0.01% 2542
2024
Q1
$6.05M Buy
429,893
+126,791
+42% +$1.78M ﹤0.01% 2349
2023
Q4
$2.33M Buy
303,102
+58,751
+24% +$451K ﹤0.01% 2906
2023
Q3
$1.82M Buy
244,351
+116
+0% +$865 ﹤0.01% 2989
2023
Q2
$2.03M Buy
244,235
+196,712
+414% +$1.64M ﹤0.01% 2996
2023
Q1
$632K Buy
47,523
+21,084
+80% +$280K ﹤0.01% 3366
2022
Q4
$394K Buy
26,439
+6,846
+35% +$102K ﹤0.01% 3580
2022
Q3
$177K Sell
19,593
-316
-2% -$2.86K ﹤0.01% 3927
2022
Q2
$60K Sell
19,909
-190
-0.9% -$573 ﹤0.01% 4347
2022
Q1
$135K Sell
20,099
-1,914
-9% -$12.9K ﹤0.01% 4257
2021
Q4
$119K Buy
22,013
+2,760
+14% +$14.9K ﹤0.01% 4372
2021
Q3
$170K Buy
19,253
+5,193
+37% +$45.9K ﹤0.01% 4244
2021
Q2
$178K Sell
14,060
-28,897
-67% -$366K ﹤0.01% 4200
2021
Q1
$745K Sell
42,957
-5,518
-11% -$95.7K ﹤0.01% 3694
2020
Q4
$623K Sell
48,475
-429
-0.9% -$5.51K ﹤0.01% 3662
2020
Q3
$1.82M Buy
48,904
+23,139
+90% +$860K ﹤0.01% 3111
2020
Q2
$994K Buy
25,765
+12,868
+100% +$496K ﹤0.01% 3360
2020
Q1
$321K Buy
12,897
+856
+7% +$21.3K ﹤0.01% 3558
2019
Q4
$427K Buy
12,041
+2,348
+24% +$83.3K ﹤0.01% 3594
2019
Q3
$314K Buy
9,693
+1,327
+16% +$43K ﹤0.01% 3651
2019
Q2
$405K Buy
8,366
+3,577
+75% +$173K ﹤0.01% 3612
2019
Q1
$228K Buy
4,789
+1,998
+72% +$95.1K ﹤0.01% 3743
2018
Q4
$73K Hold
2,791
﹤0.01% 3982
2018
Q3
$134K Buy
2,791
+2,423
+658% +$116K ﹤0.01% 3965
2018
Q2
$21K Hold
368
﹤0.01% 4210
2018
Q1
$40K Buy
368
+119
+48% +$12.9K ﹤0.01% 4105
2017
Q4
$22K Buy
249
+39
+19% +$3.45K ﹤0.01% 4150
2017
Q3
$27K Hold
210
﹤0.01% 4126
2017
Q2
$18K Hold
210
﹤0.01% 4185
2017
Q1
$20K Buy
+210
New +$20K ﹤0.01% 4152
2016
Q2
Sell
-696
Closed -$211K 4229
2016
Q1
$211K Buy
696
+51
+8% +$15.5K ﹤0.01% 3712
2015
Q4
$307K Buy
+645
New +$307K ﹤0.01% 3627